Lantheus Holdings, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Lantheus Holdings, Inc. (LNTH) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$7.07 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-01
- Lantheus Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$2.50M.
- Lantheus Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$4.56M, a 161.49% decline year-over-year.
- Lantheus Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$2.36M.
- Lantheus Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$1.05M.
- Lantheus Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $3.28M.
- Lantheus Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$13.15M.
- Lantheus Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$7.68M.
- Lantheus Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$3.48M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | -$7.07M 10-Q · filed 2017-08-01 | -$9.43M derived: sum of 3 quarters · filed 2017-08-01 | -$10.47M derived: sum of 4 quarters · filed 2017-08-01 |
| 2017-03-31 | -$4.56M 10-Q · filed 2017-05-02 | -$6.92M derived: sum of 2 quarters · filed 2017-05-02 | -$7.97M derived: sum of 3 quarters · filed 2017-05-02 | -$8.71M derived: sum of 4 quarters · filed 2017-08-01 |
| 2016-12-31 | -$2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$3.40M derived: sum of 2 quarters · filed 2017-02-23 | -$4.14M derived: sum of 3 quarters · filed 2017-08-01 | $3.28M 10-K · filed 2017-02-23 |
| 2016-09-30 | -$1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$1.78M derived: sum of 2 quarters · filed 2017-08-01 | $5.64M 10-Q · filed 2016-11-01 | $907.00K derived: sum of 4 quarters · filed 2017-08-01 |
| 2016-06-30 | -$736.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $6.69M 10-Q · filed 2017-08-01 | $1.95M derived: sum of 3 quarters · filed 2017-08-01 | -$353.00K derived: sum of 4 quarters · filed 2017-08-01 |
| 2016-03-31 | $7.42M 10-Q · filed 2017-05-02 | $2.69M derived: sum of 2 quarters · filed 2017-05-02 | $383.00K derived: sum of 3 quarters · filed 2017-05-02 | -$2.23M derived: sum of 4 quarters · filed 2017-05-02 |
| 2015-12-31 | -$4.73M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$7.04M derived: sum of 2 quarters · filed 2017-02-23 | -$9.65M derived: sum of 3 quarters · filed 2017-02-23 | -$13.15M 10-K · filed 2017-02-23 |
| 2015-09-30 | -$2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$4.92M derived: sum of 2 quarters · filed 2016-11-01 | -$8.42M 10-Q · filed 2016-11-01 | -$11.25M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | -$2.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$6.11M 10-Q · filed 2016-08-04 | -$8.95M derived: sum of 3 quarters · filed 2017-02-23 | -$10.54M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | -$3.50M 10-Q · filed 2016-05-03 | -$6.33M derived: sum of 2 quarters · filed 2017-02-23 | -$7.93M derived: sum of 3 quarters · filed 2017-02-23 | |
| 2014-12-31 | -$2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$4.43M derived: sum of 2 quarters · filed 2017-02-23 | -$7.68M 10-K · filed 2017-02-23 | |
| 2014-09-30 | -$1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$4.85M 10-Q · filed 2015-11-04 | ||
| 2014-06-30 | -$3.25M 10-Q · filed 2015-08-05 | |||
| 2013-12-31 | -$3.48M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |